MedPath

Evaluating the effect of Withania Somnifera on obsessio

Phase 2
Conditions
Obsessive-compulsive disorder.
Mixed obsessional thoughts and acts
Registration Number
IRCT2015070523079N1
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
30
Inclusion Criteria

1)Diagnosis of OCD according to DSM-IV TR.
2) Treatment with SSRI drugs with adequate dose and duration.

Exclusion criteria:
1) Pregnancy.
2) Lactation.
3) Comorbidity with other acute psychological disorders.
4) Drug abuse.
5) Liver and renal disorders.
6) Usage of other drugs that have an effect on OCD (Lithium, Gabapentin, Buspirone...).

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of OCD symptoms. Timepoint: before intervention, 6 weeks after starting the intervention. Method of measurement: Yale Brown Obsessive Compulsive Scale.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath